You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 9, March 1, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (53)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Otolaryngology/ Head & Neck Surgery
 •Endocrine Disease of Head & Neck
 •Arrhythmias
 •Thyroid/ Parathyroid Diseases
 •Alert me on articles by topic

Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults

Anne R. Cappola, MD, ScM; Linda P. Fried, MD, MPH; Alice M. Arnold, PhD; Mark D. Danese, PhD; Lewis H. Kuller, MD, DrPH; Gregory L. Burke, MD, MS; Russell P. Tracy, PhD; Paul W. Ladenson, MD

JAMA. 2006;295:1033-1041.

Context  Previous studies have suggested that subclinical abnormalities in thyroid-stimulating hormone levels are associated with detrimental effects on the cardiovascular system.

Objective  To determine the relationship between baseline thyroid status and incident atrial fibrillation, incident cardiovascular disease, and mortality in older men and women not taking thyroid medication.

Design, Setting, and Participants  A total of 3233 US community-dwelling individuals aged 65 years or older with baseline serum thyroid-stimulating hormone levels were enrolled in 1989-1990 in the Cardiovascular Health Study, a large, prospective cohort study.

Main Outcome Measures  Incident atrial fibrillation, coronary heart disease, cerebrovascular disease, cardiovascular death, and all-cause death assessed through June 2002. Analyses are reported for 4 groups defined according to thyroid function test results: subclinical hyperthyroidism, euthyroidism, subclinical hypothyroidism, and overt hypothyroidism.

Results  Individuals with overt thyrotoxicosis (n = 4) were excluded because of small numbers. Eighty-two percent of participants (n = 2639) had normal thyroid function, 15% (n = 496) had subclinical hypothyroidism, 1.6% (n = 51) had overt hypothyroidism, and 1.5% (n = 47) had subclinical hyperthyroidism. After exclusion of those with prevalent atrial fibrillation, individuals with subclinical hyperthyroidism had a greater incidence of atrial fibrillation compared with those with normal thyroid function (67 events vs 31 events per 1000 person-years; adjusted hazard ratio, 1.98; 95% confidence interval, 1.29-3.03). No differences were seen between the subclinical hyperthyroidism group and euthyroidism group for incident coronary heart disease, cerebrovascular disease, cardiovascular death, or all-cause death. Likewise, there were no differences between the subclinical hypothyroidism or overt hypothyroidism groups and the euthyroidism group for cardiovascular outcomes or mortality. Specifically, individuals with subclinical hypothyroidism had an adjusted hazard ratio of 1.07 (95% confidence interval, 0.90-1.28) for incident coronary heart disease.

Conclusion  Our data show an association between subclinical hyperthyroidism and development of atrial fibrillation but do not support the hypothesis that unrecognized subclinical hyperthyroidism or subclinical hypothyroidism is associated with other cardiovascular disorders or mortality.


Author Affiliations: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and Division of Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia (Dr Cappola); Division of Geriatric Medicine and Gerontology and Center on Aging and Health, Johns Hopkins Medical Institutions, Baltimore, Md (Dr Fried); Department of Biostatistics, University of Washington, Seattle (Dr Arnold); Outcomes Insights Inc, Newbury Park, Calif (Dr Danese); Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pa (Dr Kuller); Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC (Dr Burke); Departments of Pathology and Biochemistry, University of Vermont, Burlington (Dr Tracy); and Division of Endocrinology and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md (Dr Ladenson).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Subclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure: The Cardiovascular Health Study
Rodondi et al.
J Am Coll Cardiol 2008;52:1152-1159.
ABSTRACT | FULL TEXT  

Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies
Haentjens et al.
Eur J Endocrinol 2008;159:329-341.
ABSTRACT | FULL TEXT  

Should we treat all subjects with subclinical thyroid disease the same way?
Biondi
Eur J Endocrinol 2008;159:343-345.
FULL TEXT  

The Influence of Age on the Relationship between Subclinical Hypothyroidism and Ischemic Heart Disease: A Metaanalysis
Razvi et al.
J. Clin. Endocrinol. Metab. 2008;93:2998-3007.
ABSTRACT | FULL TEXT  

Thyroid Function and the Risk of Alzheimer Disease: The Framingham Study
Tan et al.
Arch Intern Med 2008;168:1514-1520.
ABSTRACT | FULL TEXT  

Cardiovascular Consequences of Subclinical Thyroid Dysfunction: More Smoke but No Fire
Ladenson
ANN INTERN MED 2008;148:880-881.
FULL TEXT  

Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ochs et al.
ANN INTERN MED 2008;148:832-845.
ABSTRACT | FULL TEXT  

Retinol Binding Protein-4 Elevation Is Associated with Serum Thyroid-Stimulating Hormone Level Independently of Obesity in Elderly Subjects with Normal Glucose Tolerance
Choi et al.
J. Clin. Endocrinol. Metab. 2008;93:2313-2318.
ABSTRACT | FULL TEXT  

Thyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study
Asvold et al.
Arch Intern Med 2008;168:855-860.
ABSTRACT | FULL TEXT  

Thyroid Function and Lipid Subparticle Sizes in Patients with Short-Term Hypothyroidism and a Population-Based Cohort
Pearce et al.
J. Clin. Endocrinol. Metab. 2008;93:888-894.
ABSTRACT | FULL TEXT  

The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi and Cooper
Endocr. Rev. 2008;29:76-131.
ABSTRACT | FULL TEXT  

Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk
Raterman et al.
Ann Rheum Dis 2008;67:229-232.
ABSTRACT | FULL TEXT  

Upper Limit of Normal Serum Thyroid-Stimulating Hormone: A Moving and Now an Aging Target?
Fatourechi
J. Clin. Endocrinol. Metab. 2007;92:4560-4562.
FULL TEXT  

Update in Endocrinology
Schlechte
ANN INTERN MED 2007;147:563-572.
FULL TEXT  

Thyroid Disease and the Heart
Klein and Danzi
Circulation 2007;116:1725-1735.
ABSTRACT | FULL TEXT  

Subclinical Thyroid Dysfunction and the Heart
Cappola
J. Clin. Endocrinol. Metab. 2007;92:3404-3405.
FULL TEXT  

Association Between Increased Mortality and Mild Thyroid Dysfunction in Cardiac Patients
Iervasi et al.
Arch Intern Med 2007;167:1526-1532.
ABSTRACT | FULL TEXT  

Serum Thyrotropin Measurements in the Community: Five-Year Follow-up in a Large Network of Primary Care Physicians
Meyerovitch et al.
Arch Intern Med 2007;167:1533-1538.
ABSTRACT | FULL TEXT  

The Association of Thyroid Dysfunction with All-Cause and Circulatory Mortality: Is There a Causal Relationship?
Volzke et al.
J. Clin. Endocrinol. Metab. 2007;92:2421-2429.
ABSTRACT | FULL TEXT  

Reply
Gammage et al.
J Am Coll Cardiol 2007;49:2229-2230.
FULL TEXT  

Hyperthyroidism and Mortality
Volzke
J Am Coll Cardiol 2007;49:2228-2229.
FULL TEXT  

Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation
Gammage et al.
Arch Intern Med 2007;167:928-934.
ABSTRACT | FULL TEXT  

The Beneficial Effect of L-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial
Razvi et al.
J. Clin. Endocrinol. Metab. 2007;92:1715-1723.
ABSTRACT | FULL TEXT  

Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials
Walter et al.
BMJ 2007;334:514-514.
ABSTRACT | FULL TEXT  

Cardiovascular Manifestations of Hyperthyroidism Before and After Antithyroid Therapy: A Matched Case-Control Study
Osman et al.
J Am Coll Cardiol 2007;49:71-81.
ABSTRACT | FULL TEXT  

Approach to the Patient with Subclinical Hyperthyroidism
Cooper
J. Clin. Endocrinol. Metab. 2007;92:3-9.
ABSTRACT | FULL TEXT  

Prevalence of Subclinical Thyroid Dysfunction and Its Relation to Socioeconomic Deprivation in the Elderly: A Community-Based Cross-Sectional Survey
Wilson et al.
J. Clin. Endocrinol. Metab. 2006;91:4809-4816.
ABSTRACT | FULL TEXT  

Other articles noted
Evid. Based Med. 2006;11:95-96.
FULL TEXT  

Endocrinology & Metabolism News, April 2006
J. Clin. Endocrinol. Metab. 2006;91:17a-17a.
FULL TEXT  

What's new in the other general journals
Tonks
BMJ 2006;332:597-598.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.